- Filed
- May 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 15, 2025 | 117.4M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 174.02M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 172.18M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 170.99M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 170.05M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $40.69K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $72.28K |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $716.43K |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $533.16K |
| Current Assets | Q3 2025 · Mar 31, 2025 | $40.69K |
| Current Assets | Q3 2025 · Jun 30, 2024 | $72.28K |
| Total Assets | Q3 2025 · Mar 31, 2025 | $315.11K |
| Total Assets | Q3 2025 · Jun 30, 2024 | $366.62K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$120.67K |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $489.32K |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $569.55K |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $99.7K |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $287.1K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$121.13K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$324.81K |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$117.63K |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$317.7K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | −$16.58K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | −$26.76K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $25.05K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $80.69K |
| Revenue | Q3 2025 · Mar 31, 2024 | $8.47K |
| Revenue | Q3 2025 · Mar 31, 2024 | $53.93K |